Learn the dynamics of psoriasis treatments, emphasizing patient adherence challenges. From evolving therapies to oral and biologic agents, understand real-world
The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023, in
The prognosis and maintenance of response after treatment discontinuation following remission lack proper characterization. Real-world data obtained from national registries
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Biológicos e biossimilares criaram muitas novas opções no tratamento da psoríase para pacientes em todo o mundo, mas os pacientes
Los productos biológicos y biosimilares han creado muchas opciones nuevas en el tratamiento de la psoriasis para pacientes de todo
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
In the April 2021 issue of the Lancet, four of our esteemed colleagues in the IPC published an updated and
According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at
